Enlivex Therapeutics stock price

NASDAQ:ENLV · Nasdaq · Healthcare · sector #16
$0.2022-9.61%Oct 21 close
Loading chart…

Enlivex Therapeutics's chart data is dated 2026-10-21. There is no active technical signal. The display ticker is ENLV.

Enlivex Therapeutics last closed at $0.2022 (-9.61%) on 2026-10-21. Listed on Nasdaq. Trailing 12 months PER is 0.0×. Its overall grade ranks 407 of 727 stocks in Healthcare.

About this company

Enlivex Therapeutics last closed at $0.2022 (-9.61%) on 2026-10-21. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall B- · 407/727

Valuation grade B-

Details →

Related stocks

  • AstraZenecaCompetitor
  • PfizerCompetitor
  • NovartisCompetitor
Details →
About Enlivex Therapeutics
What technical signals does Enlivex Therapeutics (ENLV) have?
Enlivex Therapeutics current technical signals: no active technical signal.
Is Enlivex Therapeutics a cup-and-handle pattern?
No. Enlivex Therapeutics has no valid Cup signal right now.
What published figures are available for Enlivex Therapeutics?
Market cap: $3.2M. Trailing 12 months PER: 0.0×. Latest quarter PBR: 0.00×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Turn what you saw on this name into a strategy

Ask Q about Enlivex Therapeutics, or open the plan table on the main site.

Ask Q about Enlivex Therapeutics.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Enlivex Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy